Irritable bowel syndrome screening: Difference between revisions
| Line 13: | Line 13: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
Revision as of 18:56, 1 November 2017
|
Irritable bowel syndrome Microchapters |
|
Differentiating Irritable bowel syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Irritable bowel syndrome screening On the Web |
|
American Roentgen Ray Society Images of Irritable bowel syndrome screening |
|
Risk calculators and risk factors for Irritable bowel syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].